| Quantity | Price per tablet | You save | Total price | |
|---|---|---|---|---|
| 60 | $1.52 | - | $91.00 | |
| 90 | $1.37 | $13.50 | $123.00 | |
| 120 | $1.29 | $27.00 | $155.00 | |
| 180 | $1.23 | $52.00 | $221.00 | |
| 270 | $1.17 | $92.50 | $317.00 | |
| 360 | $1.15 | $132.00 | $414.00 |
| Quantity | Price per tablet | You save | Total price | |
|---|---|---|---|---|
| 60 | $1.48 | - | $89.00 | |
| 90 | $1.22 | $23.50 | $110.00 | |
| 180 | $0.97 | $93.00 | $174.00 | |
| 360 | $0.85 | $229.00 | $305.00 |
| Quantity | Price per tablet | You save | Total price | |
|---|---|---|---|---|
| 30 | $3.20 | - | $96.00 | |
| 60 | $2.50 | $42.00 | $150.00 | |
| 90 | $2.28 | $83.00 | $205.00 | |
| 120 | $2.14 | $127.00 | $257.00 | |
| 180 | $2.03 | $211.00 | $365.00 | |
| 270 | $1.95 | $338.00 | $526.00 | |
| 360 | $1.91 | $466.00 | $686.00 |
| Quantity | Price per tablet | You save | Total price | |
|---|---|---|---|---|
| 30 | $3.10 | - | $93.00 | |
| 60 | $2.23 | $52.00 | $134.00 | |
| 90 | $1.94 | $104.00 | $175.00 | |
| 120 | $1.82 | $154.00 | $218.00 | |
| 180 | $1.67 | $257.00 | $301.00 | |
| 270 | $1.58 | $411.00 | $426.00 |
Your order is carefully packed and ships within 24 hours. Here's the typical package.
Sized like a regular personal letter (9.4x4.3x0.3 inches), with no indication of its contents.
| Shipping Method | Estimated delivery |
|---|---|
| Express Free for orders over $300.00 | Estimated delivery to the U.S.: 4-7 days |
| Standard Free for orders over $200.00 | Estimated delivery to the U.S.: 14-21 days |
| Country | Brand Names |
|---|---|
| United Kingdom | Adartrel |
| Canada | Apo-Ropinirole |
| New Zealand | Ropin |
Our Requip product listing covers immediate-release ropinirole tablets taken by mouth. We offer four strengths: 0.25 mg, 0.5 mg, 1 mg, and 2 mg. Available package quantities range from 30 to 360 tablets, although not every count is offered for every strength. The practical decision is therefore not simply which package has the lowest unit cost. It is which available strength and quantity correspond to the current prescription, expected duration at that strength, and likelihood that the regimen will change.
Ropinirole is a dopamine agonist used for Parkinson's disease and moderate-to-severe primary restless legs syndrome. Its dose is individualized and usually adjusted gradually, so a package that suits an established regimen may not suit someone who is beginning treatment or undergoing a dose change. Before comparing package value, confirm whether the prescription is for immediate-release ropinirole tablets and check the exact strength, number of tablets per dose, dosing frequency, and intended duration.
The options on this page should not be confused with an extended-release ropinirole product. Release type affects dosing and cannot be changed merely by choosing a tablet with the same active ingredient. Our listed options are oral immediate-release tablets in the strengths shown above.
The comparison below presents the package quantities, current prices, unit values, and relative savings available from us. It is the appropriate place to compare exact current figures without relying on outside prices or assumed market averages.
Unit value can help distinguish between two medically suitable quantities, but it should remain secondary to the prescribed regimen. A larger count may reduce the cost per tablet, yet that difference is useful only when the same strength is expected to remain appropriate and the tablets can be used before the labeled expiration date. A smaller package may be more sensible when treatment is being started, tolerability is still being assessed, or the prescriber expects to review the dose soon.
Package availability varies by strength, so begin with the prescribed strength and then compare the quantities we offer within that option. Avoid calculating value across different strengths as though the tablets were interchangeable. Two 0.5 mg tablets contain the same total amount of ropinirole as one 1 mg tablet, but that arithmetic alone does not establish that the substitution is appropriate for a particular prescription.
Ropinirole dosing differs between Parkinson's disease and restless legs syndrome, and it may also change during treatment. The lower tablet strengths allow smaller dose increments, while the 1 mg and 2 mg tablets provide other ways to assemble a prescribed dose. None of these strengths is automatically a starter, maintenance, or preferred option for every patient.
A useful review before selecting a package includes:
If the directions require more than one tablet at a time or combine strengths, do not redesign the regimen solely to obtain a different package value. A prescriber or pharmacist should confirm whether an alternative tablet combination is clinically and practically appropriate. Tablets should not be split unless the specific product labeling or a healthcare professional says that the tablet may be divided.
Requip is the established brand name for ropinirole. The immediate-release branded product was approved in the United States under NDA 020658, but the original branded product is listed by the FDA as discontinued. That status does not mean ropinirole itself has been withdrawn from clinical use; prescription generic ropinirole tablets remain part of current treatment.
Our use of the Requip name identifies the product and active ingredient being compared on this page. It should not be taken as a claim that every package is the discontinued original branded formulation. The manufacturer and labeling shown for a selected option should be reviewed during ordering. Generic products contain the same active ingredient and strength as their reference product and must meet applicable regulatory standards, but inactive ingredients, tablet appearance, packaging, and manufacturer may differ.
When continuity of manufacturer or tablet appearance matters, check the available listing before completing our checkout. A change in color, shape, or imprint should not be judged by appearance alone; the dispensing label and product identification provide the relevant details. Anyone uncertain about a received tablet should consult a pharmacist before taking it.
Immediate-release ropinirole tablets are used in adults for Parkinson's disease and for moderate-to-severe primary restless legs syndrome. In Parkinson's disease, ropinirole may help manage symptoms associated with impaired dopamine signaling, including slowness, stiffness, and movement difficulties. It may be used alone in some circumstances or with other Parkinson's medicines, depending on the treatment plan.
For primary restless legs syndrome, ropinirole can reduce the urge to move the legs and the uncomfortable sensations that commonly occur during rest, particularly in the evening. Restless legs symptoms can have other causes or be worsened by another condition or medicine, so a correct diagnosis matters before treatment begins. Ropinirole is not a general sleep aid, and it is not appropriate for every type of nighttime leg discomfort.
Alternatives depend on the condition being treated. Other dopamine agonists include pramipexole and rotigotine. Parkinson's treatment may also involve levodopa/carbidopa, rasagiline, selegiline, amantadine, or other medicines. Gabapentin enacarbil is another option used for restless legs syndrome in suitable patients. These products differ in dosage form, schedule, risks, and approved uses, so they are not direct package-for-package substitutes.
Ropinirole is a non-ergoline dopamine agonist. It activates dopamine receptors rather than replacing dopamine directly. This action can improve dopaminergic signaling involved in movement and in the sensory and motor features of restless legs syndrome.
Administration schedules are not the same for the two established uses. Immediate-release ropinirole for Parkinson's disease is generally taken on a different schedule from ropinirole for restless legs syndrome. Follow the directions supplied by the prescriber and on the dispensing label rather than transferring instructions from one condition to another.
General practical points include:
Store the tablets at 68°F to 77°F. Brief excursions from 59°F to 86°F are permitted. Protect them from light and moisture, and keep them in the original tightly closed container. Keep all medicines out of the reach of children.
Ropinirole can cause sleepiness and sudden sleep onset, sometimes without clear warning. These events have occurred during driving and other activities that require alertness. Until its effects are known, avoid driving, operating machinery, or performing hazardous tasks if sleepiness occurs. Alcohol and other sedating substances can increase impairment.
Dizziness, nausea, fainting, and a drop in blood pressure when standing can occur, particularly when treatment begins or the dose increases. Rise carefully from sitting or lying positions. Hallucinations, confusion, involuntary movements, and changes in behavior may also occur. Dopamine agonists have been associated with intense urges involving gambling, shopping, eating, or sexual behavior. Patients and family members should report new or difficult-to-control urges promptly.
Important points to review include:
Seek prompt medical attention for loss of consciousness, severe allergic symptoms, severe confusion, dangerous sleep episodes, or other serious reactions. This overview does not replace the product labeling or individualized advice from a prescriber or pharmacist.
Ropinirole tablets are prescription drugs in the United States. That regulatory classification is separate from our ordering policy. We do not require customers to submit a prescription through our checkout, but our policy does not change the medicine's prescription status or remove the need for appropriate medical supervision.
Ropinirole requires an accurate diagnosis, gradual dose selection, and monitoring for adverse effects. A prescriber should determine the indication, release type, strength, schedule, and duration. This is particularly important when treatment is being started, a dose is being changed, another medicine is added or stopped, or troublesome sleepiness and behavioral effects occur.
Before ordering, compare the selected option with the current prescription or dispensing label. If the strength, tablet type, or directions do not match, resolve the difference with a healthcare professional rather than estimating an equivalent regimen.
After selecting a strength, our checkout displays the package quantities we currently offer for that strength. Customers can review our listed price and selected quantity before completing payment. We then pack and dispatch the order for delivery using the information provided during checkout.
Our support team is available 24/7 by email and online chat for questions about our listings, checkout, payment, and order status. A pharmacist is also available for general questions about the medicine, labeled storage, and the distinction between available strengths or release types. Our pharmacist does not replace the prescriber who determined the individual regimen, and we do not recommend changing a prescribed dose to fit a package option.
Review the delivery address carefully, including the ZIP code, before submitting the order. When the package arrives, compare the product name, active ingredient, strength, quantity, and label with the order. Keep the medicine in its original container and contact our support team if the received order does not match the confirmed selection. Questions about whether the medicine itself is appropriate should be directed to a prescriber or pharmacist before use.
The most suitable option begins with medical accuracy: immediate-release oral ropinirole tablets in the prescribed strength and a quantity consistent with the expected duration of use. Only after those points match should unit value influence the comparison.
Use the package-value element near the beginning of this guide to compare our current options. A lower unit cost can be useful when the dose is stable and the quantity is likely to be used appropriately, but it does not make a larger package medically preferable. Conversely, a smaller package may carry a different unit value while limiting unused tablets if the prescriber expects an early review or dose adjustment.
Before completing our checkout, verify the strength, directions, package count, current price, storage requirements, and delivery details. That approach keeps the financial comparison connected to the actual prescription and avoids treating package size alone as the measure of value.
I'm ordering from Charlotte and do not want to receive tablets that expire soon. Can you tell me how much shelf life will be left?
We cannot promise a specific remaining shelf life before an order is packed. Check the expiration date printed on the received medicine package before use.
I may need to reorder later. Will I receive ropinirole from the same manufacturer each time?
We cannot guarantee the same manufacturer on future orders. When a package arrives, verify the active ingredient, strength, dosage form, manufacturer, lot number, and expiration date on its label.
I know the name Requip from my old prescription. Will my package show that brand name, or could it have a different name?
The exact trade name on the supplied package cannot be guaranteed. It may show a generic or manufacturer name instead; confirm that the label identifies ropinirole tablets in the strength you ordered.
My delivery arrived in Jacksonville, and the medicine package seal looks torn. Is it safe to start taking the tablets?
Do not use tablets from a package with a seal or physical condition that appears compromised until the discrepancy is checked. Keep the package, including its label, lot number, and expiration date, for verification.
I drive early-morning routes for work in Fort Worth. Can I drive after starting ropinirole?
Ropinirole can cause dizziness, drowsiness, or sudden sleep episodes, sometimes without warning. Do not drive or operate machinery if you feel sleepy, dizzy, or have fallen asleep unexpectedly; sudden sleep episodes should be discussed promptly with the prescriber.
| Active ingredient | Ropinirole |
|---|---|
| Drug class | Dopamine agonist |
| Dosage form | Tablet |
| Available strengths | 0.25 mg, 0.5 mg, 1 mg, 2 mg |
| Route | Oral |
| Storage | Store at 68°F to 77°F; brief excursions permitted from 59°F to 86°F. Protect from light and moisture, and keep in the original tightly closed container. |
| ATC code | N04BC04 |
This product has 19 ratings, but only 4 written reviews so far. Share your experience and help other customers.
Everything went really well.
I appreciated the neutral outer packaging on my order.
The 0.5 mg pack of 120 was practical. It was the better choice.
I found the seals intact, and nothing inside was damaged.